findmyKOL

Adrian Ma, MD

Basic profile

Stanford Health Care

ORCIDNone on fileNPI
RegionSan Jose, CA · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Adrian Ma is a Cardiology physician affiliated with Stanford Health Care. OpenAlex indexes 12 publications with 3,789 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
12publications

Distinct works indexed by OpenAlex.

3,789citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

200 Jose Figueres Ave Ste 215
Ste 215
San Jose, CA 951161588

Telephone

408-729-3388

Registry record last updated 9 Dec 2012.

View the NPPES registry record

Industry payments

15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    72.4%
    Beta blocker18.4%
    Metoprolol Succinate46%Carvedilol22%Sotalol16%Metoprolol Tartrate11%Atenolol3%Propranolol Hcl1%Bisoprolol Fumarate1%
    Part D<11 patients
    Adenosine Receptor Agonist12.1%
    Regadenoson100%
    Part B, office-administered201 patients

    + 19 more classes in this area

  • Blood & clotting

    18.7%
    Factor Xa inhibitor13.9%
    Eliquis81%Xarelto19%
    Part D161 patients
    P2Y12 inhibitor4.1%
    Clopidogrel88%Brilinta12%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    7%
    Potassium supplement2.9%
    Potassium Chloride87%Klor-Con 1014%
    Part D52 patients
    SGLT2 inhibitor2.2%
    Jardiance68%Farxiga32%
    Part D23 patients

    + 4 more classes in this area

Where care is delivered (Part B)4.8% facility · 95.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”